EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Asia Pacific

Takeda’s Alunbrig improves PFS in phase 3 lung cancer trial

Takeda’s lung cancer drug Alunbrig (brigatinib) has significantly improved progression-free survival (PFS) in phase 3 ALTA-1L (ALK in lung cancer trial of AP26113 in ...
Continue Reading →
Asia Pacific

Pfizer’s Innovative drug IBRANCE gets China approval

World's First Kinase 4/6 (CDK 4/6) Inhibitor and Only Innovative Breakthrough Therapy for Advanced Breast Cancer in China over Past Ten Years Pfizer China announced ...
Continue Reading →
Asia Pacific

Eisai inks deal with Taiwan’s CY Biotech

The deal grants CY Biotech with exclusive development and marketing rights for its anti-obesity agent lorcaserin in China Japan-based Eisai recently announced that i...
Continue Reading →
Asia Pacific

FDA issues new guidelines for opioid use disorders meds

The draft guidelines could make it easier for new treatments to be developed, as clinical trials can be based on other patient outcomes beyond reduction in drug use. ...
Continue Reading →
Asia Pacific

iGlucose ,Validic unite to simplify Diabetes management

Together, the companies bring a simple, convenient and affordable diabetes management solution to people with diabetes, healthcare teams and population management pro...
Continue Reading →
Asia Pacific

Mushrooms of the Far East hold promise for the anti-cancer therapy

Mushrooms from the Far East area contain the natural chemical compounds, which could be used for the design of the novel drugs with highly specific anti-tumor activit...
Continue Reading →
Asia Pacific

HUJI gets an ultra-high resolution U-CT system

The researchers at Blum Lab will be using the MILabs’ ultra-high resolution CT to detect novel gold labeled probes in cancerous tissue as well as in atherosclerotic p...
Continue Reading →
Asia Pacific

First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson’s

Jun Takahashi (left) and colleagues explained their plans for a trial in Parkinson’s disease patients at a press confer...
Continue Reading →
Asia Pacific

Hadassah Medical Center Joins TriNetX to Increase Clinical Trial Collaboration Efforts with Pharma

Hadassah Medical Center, a leading healing, teaching, and research hospital in Jerusalem, Israel, is the first medical center in the country to join the TriNetX globa...
Continue Reading →
Asia Pacific

Korea’s ViroMed acquires DNA-producing facility for clinical trial in U.S.

ViroMed, a Korean developer of biologic drugs, Wednesday announced it has acquired a DNA production facility in San Diego, California, adding a manufacturing function...
Continue Reading →
Catalyst: 12th January 2026
Quotient